NUAK2 and liver cancer: Studies performed in mouse models (e.g., YAP-inducible overexpression mouse models that cause hepatomegaly and eventually liver tumorigenesis) of liver cancer indicate that NUAK2 knockdown decreases cell proliferation in YAP-dependent liver tumors and HuCCT cells.